These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 33161301)
1. Strategies to prevent hemorrhagic transformation after reperfusion therapies for acute ischemic stroke: A literature review. Otsu Y; Namekawa M; Toriyabe M; Ninomiya I; Hatakeyama M; Uemura M; Onodera O; Shimohata T; Kanazawa M J Neurol Sci; 2020 Dec; 419():117217. PubMed ID: 33161301 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke. Kanazawa M; Takahashi T; Nishizawa M; Shimohata T J Atheroscler Thromb; 2017 Mar; 24(3):240-253. PubMed ID: 27980241 [TBL] [Abstract][Full Text] [Related]
3. Impact of Decompressive Craniectomy on Hemorrhagic Transformation in Malignant Ischemic Stroke in Mice. Borha A; Lebrun F; Touzé E; Emery E; Vivien D; Gaberel T Stroke; 2023 Jan; 54(1):e1-e6. PubMed ID: 36475467 [TBL] [Abstract][Full Text] [Related]
4. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice. García-Yébenes I; García-Culebras A; Peña-Martínez C; Fernández-López D; Díaz-Guzmán J; Negredo P; Avendaño C; Castellanos M; Gasull T; Dávalos A; Moro MA; Lizasoain I Stroke; 2018 Sep; 49(9):2163-2172. PubMed ID: 30018160 [TBL] [Abstract][Full Text] [Related]
5. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke. Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547 [TBL] [Abstract][Full Text] [Related]
6. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator. Ong CT; Wong YS; Wu CS; Su YH Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721 [TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier permeability assessed by perfusion computed tomography predicts hemorrhagic transformation in acute reperfusion therapy. Kim T; Koo J; Kim SH; Song IU; Chung SW; Lee KS Neurol Sci; 2018 Sep; 39(9):1579-1584. PubMed ID: 29909558 [TBL] [Abstract][Full Text] [Related]
8. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Bang OY; Saver JL; Kim SJ; Kim GM; Chung CS; Ovbiagele B; Lee KH; Liebeskind DS; Stroke; 2011 Aug; 42(8):2235-9. PubMed ID: 21737798 [TBL] [Abstract][Full Text] [Related]
9. Thrombolytic strategies for ischemic stroke in the thrombectomy era. Gauberti M; Martinez de Lizarrondo S; Vivien D J Thromb Haemost; 2021 Jul; 19(7):1618-1628. PubMed ID: 33834615 [TBL] [Abstract][Full Text] [Related]
10. Predictors of hemorrhagic transformation differences between patients treated or not with reperfusion therapy. Brainer Clares de Andrade J; Mohr JP; Oliveira Lima F; José de Freitas Carvalho J; Andre Castro de Oliveira R; Coelho Maia Barros L; Sampaio Silva G J Clin Neurosci; 2022 Jul; 101():9-15. PubMed ID: 35500307 [TBL] [Abstract][Full Text] [Related]
11. Automatic triaging of acute ischemic stroke patients for reperfusion therapies using Artificial Intelligence methods and multiple MRI features: A review. Ben Alaya I; Limam H; Kraiem T Clin Imaging; 2023 Dec; 104():109992. PubMed ID: 37857099 [TBL] [Abstract][Full Text] [Related]
12. Age-specific trends in intravenous thrombolysis and mechanical thrombectomy utilization in acute ischemic stroke in children under age 18. Kaur N; Patel S; Ayanbadejo MO; Hoffman H; Akano E; Anikpezie N; Aneni E; Lamikanra O; Wee C; Albright K; Khandelwal P; Latorre JG; Chaturvedi S; Otite FO Int J Stroke; 2023 Apr; 18(4):469-476. PubMed ID: 36250237 [TBL] [Abstract][Full Text] [Related]
13. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation. Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW; Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765 [TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers. Wang W; Li M; Chen Q; Wang J Mol Neurobiol; 2015 Dec; 52(3):1572-1579. PubMed ID: 25367883 [TBL] [Abstract][Full Text] [Related]
15. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score. Skagen K; Skjelland M; Russell D; Jacobsen EA J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156 [TBL] [Abstract][Full Text] [Related]
16. Current and future recanalization strategies for acute ischemic stroke. Alexandrov AV J Intern Med; 2010 Feb; 267(2):209-19. PubMed ID: 20175867 [TBL] [Abstract][Full Text] [Related]
17. Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment. Knecht T; Story J; Liu J; Davis W; Borlongan CV; Dela Peña IC Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257093 [TBL] [Abstract][Full Text] [Related]
18. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis. Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451 [TBL] [Abstract][Full Text] [Related]
19. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341 [TBL] [Abstract][Full Text] [Related]